Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of Directors
- Tuesday, December 22, 2020, 7:17
- PR Newswire
- Add a comment
CAMBRIDGE, Mass., Dec. 22, 2020 /PRNewswire/ — Q32 Bio, a biotechnology company developing therapeutics to restore healthy immune regulation, today announced the appointment of industry leader Mark Iwicki as Chairman of its Board of Directors. Mr. Iwicki will succeed Dr. David Grayzel as…
About the Author
admin has written 21717 stories on this site.